The governor of New York recently signed legislation mandating that the state immediately reschedule or deschedule Schedule I drugs like MDMA and psilocybin if they’re reclassified under federal law.
The companion Assembly and Senate bills, signed by Gov. Kathy Hochul (D) late last month, are meant to “provide for parity between the New York State schedule and the federal schedule when certain drugs are approved for medical treatment,” a memo from the sponsors says.
Assemblymember Donna Lupardo (D) and Sen. Gustavo Rivera (D) sponsored the identical proposals in their respective chambers, carrying them through the committee process and to the floor with unanimous support. Hochul’s action was first noted by Lucid News this week.
While the newly enacted law applies to all Schedule I drugs, the sponsor memo explicitly references MDMA and psilocybin as examples of the types of substances that prompted lawmakers to advance the reform.
Now, if federal drug scheduling statute changes while the state legislature is out of session, the “drug products will be available for administration by medical providers to ensure that there are no gaps in services.”
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this
Read full article on Marijuana Moment
